Q1 2025 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2025-05-13 · accession 0000945621-25-000464
$312.2M
Reported value
33
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $26.5M | 8.50% | 435,000 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $23.4M | 7.51% | 925,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $18.8M | 6.02% | 82,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $18.4M | 5.90% | 205,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $18.4M | 5.89% | 59,000 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $16.3M | 5.21% | 98,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $15.7M | 5.02% | 140,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $13.7M | 4.38% | 202,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $12.9M | 4.12% | 113,631 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $12.5M | 4.01% | 28,779 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $12.1M | 3.88% | 88,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $10.7M | 3.44% | 177,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $9.7M | 3.11% | 137,348 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $9.6M | 3.08% | 159,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $8.9M | 2.86% | 123,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $8.8M | 2.83% | 211,970 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $8.6M | 2.76% | 285,842 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $8.5M | 2.72% | 247,650 | Common | SOLE |
| N72482206 | QGEN | QIAGEN NV | $7.5M | 2.40% | 187,000 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $6.6M | 2.12% | 25,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $5.8M | 1.85% | 43,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $5.0M | 1.60% | 477,073 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $5.0M | 1.60% | 62,000 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $4.7M | 1.51% | 92,250 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $3.5M | 1.11% | 180,523 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $3.4M | 1.08% | 13,829 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $2.7M | 0.88% | 30,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.6M | 0.85% | 17,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $2.6M | 0.82% | 18,639 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $2.4M | 0.78% | 25,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $2.3M | 0.74% | 35,000 | Common | SOLE |
| 83444M101 | SOLV | SOLVENTUM CORP | $2.3M | 0.73% | 30,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2.2M | 0.69% | 55,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.